1. Mullington JN, Haack M, Toth M, et al. Cardiovascular, inflammatory and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis. 2009; 51: 294–302.
1a. Redline S, Kump K, Tishler PV, et al. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med. 1994; 149: 722–726.
2. Kessler RC, Berglund PA, Coulouvrat C, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011; 34: 1161–1171.
3. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002; 6: 97–111.
4. Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006; 29: 85–93.
5. Krystal AD, Edinger J, Wohlgemuth W, et al. Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev. 1998; 2: 243–253.
6. Hachul H, Bittencourt LR, Soares JM Jr, et al. Sleep in post-menopausal women: differences between early and late post-menopause. Eur J Obstet Gynecol Reprod Biol. 2009; 145: 81–84.
7. Palesh OG, Roscoe JA, Mustian KM, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010; 28: 292–298.
8. Omisade A, Buxton OM, Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav. 2012; 99: 651–656.
9. Van Cauter E, Copinschi GL, Turek FW. Endocrine and other biological rhythms. in DeGroot LJ, Jameson JL. (eds): Endocrinology. Philadelphia, WB Saunders, 2001; , Vol 1:, 4th ed, pp 341–372.
10. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N Engl J Med. 1988; 319: 348–353.
11. Spiegel K, Tasali E, Penev P, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004; 141: 846–850.
12. International Classification of Sleep Disorders), Second Edition: Diagnostic and Coding Manual. Westchester, IL, American Academy of Sleep Medicine, 2005.
13. Lauderdale DS, Knutson KL, Yan LL, et al. Objectively measured sleep characteristics among early-middle-aged adults: the CARDIA study. Am J Epidemiol. 2006; 164: 5–16.
14. Morgenthaler T, Kramer M, Alessi C, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep. 2006; 29: 1415–1419.
15. Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008; 4: 487–504.
16. Krystal AD. Insomnia in women. Clin Cornerstone. 2003; 5: 41–50.
17. Epstein DR, Dirksen SR. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum. 2007; 34: E51–E59.
18. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep. 1999; 22: 667–689.
19. Young T, Blustein J, Finn L, et al. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep. 1997; 20: 608–613.
20. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328: 1230–1235.
21. Young T, Evans L, Finn L, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997; 20: 705–706.
22. Young T, Peppard PE. Clinical presentation of OSAS: gender does matter. Sleep. 2005; 28: 293–295.
23. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med. 2002; 162: 893–900.
24. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep. 2005; 28: 309–314.
25. Epstein LJ, Kristo D, Strollo PJ Jr, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009; 5: 263–276.
26. Walker RP, Durazo-Arvizu R, Wachter B, et al. Preoperative differences between male and female patients with sleep apnea. Laryngoscope. 2001; 111: 1501–1505.
27. Richman RM, Elliott LM, Burns CM, et al. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994; 18: 173–177.
28. Bixler EO, Papaliaga MN, Vgontzas AN, et al. Women sleep objectively better than men and the sleep of young women is more resilient to external stressors: effects of age and menopause. J Sleep Res. 2009; 18: 221–228.
29. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001; 163: 608–613.
30. Polo-Kantola P, Rauhala E, Helenius H, et al. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. Obstet Gynecol. 2003; 102: 68–75.
31. Dennerstein L, Lehert P, Guthrie JR, et al. Modeling women’s health during the menopausal transition: a longitudinal analysis. Menopause. 2007; 14: 53–62.
32. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause. 1999; 6: 196–200.
33. Prinz P, Bailey S, Moe K, et al. Urinary free cortisol and sleep under baseline and stressed conditions in healthy senior women: effects of estrogen replacement therapy. J Sleep Res. 2001; 10: 19–26.
34. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 1998; 280: 605–613.
35. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009; 373: 82–93.
36. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004; 110: 364–367.
37. Neuberger HR, Schotten U, Verheule S, et al. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation. 2005; 111: 30–37.
38. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010; 7: 677–685.
39. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med. 2012; 156: 115–122.
40. Aronsohn RS, Whitmore H, Van Cauter E, et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. 2010; 181: 507–513.
41. Hassaballa HA, Tulaimat A, Herdegen JJ, et al. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath. 2005; 9: 176–180.
42. Valham F, Stegmayr B, Eriksson M, et al. Snoring and witnessed sleep apnea is related to diabetes mellitus in women. Sleep Med. 2009; 10: 112–117.
43. Tasali E, Chapotot F, Leproult R, et al. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011; 96: 365–374.
44. Berry RB. Fundamentals of Sleep Medicine. Philadelphia, Elsevier Saunders, 2012.
45. Nino-Murcia G, McCann CC, Bliwise DL, et al. Compliance and side effects in sleep apnea patients treated with nasal continuous positive airway pressure. West J Med. 1989; 150: 165–169.
46. Sin DD, Mayers I, Man GC, et al. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest. 2002; 121: 430–435.
47. Battagel JM, Johal A, L’Estrange PR, et al. Changes in airway and hyoid position in response to mandibular protrusion in subjects with obstructive sleep apnoea (OSA). Eur J Orthod. 1999; 21: 363–376.
48. Campos-Rodriguez F, Martinez-Garcia MA, et al. Gender differences in treatment recommendations for sleep apnea. Clin Pract. 2012; 9: 565–578.
49.Deleted in proof.
50. Yeboah J, Redline S, Johnson C, et al. Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis. 2011; 219: 963–968.
51. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6: e1000132
52. Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med. 2009; 169: 1619–1626.
53. Blyton DM, Skilton MR, Edwards N, et al. Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep. 2013; 36: 15–21.
54. Tom SE, Anderson ML, Landis CA, et al. Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trial. Menopause. 2011; 18: 1184–1190.
55. Maasilta P, Bachour A, Teramo K, et al. Sleep-related disordered breathing during pregnancy in obese women. Chest. 2001; 120: 1448–1454.
56. Ye L, Pien GW, Ratcliffe SJ, et al. Gender differences in obstructive sleep apnea and treatment response to continuous positive airway pressure. J Clin Sleep Med. 2009; 5: 512–518.
57. Jayaraman G, Majid H, Surani S, et al. Influence of gender on continuous positive airway pressure requirements in patients with obstructive sleep apnea syndrome. Sleep Breath. 2011; 15: 781–784.
58. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4: 101–119.
59. Berger K, Kurth T. RLS epidemiology—frequencies, risk factors and methods in population studies. Mov Disord. 2007; 22: S420–S423.
60. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004; 5: 237–246.
61. Winter AC, Schurks M, Glynn RJ, et al. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open. 2012; 2: e000866
62. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000; 54: 1064–1068.
63. Paulus W, Dowling P, Rijsman R, et al. Pathophysiological concepts of restless legs syndrome. Mov Disord. 2007; 22: 1451–1456.
64. Earley CJ, Allen RP, Beard JL, et al. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res. 2000; 62: 623–628.
65. Allen RP. Race, iron status and restless legs syndrome. Sleep Med. 2002; 3: 467–468.
66. Li Y, Walters AS, Chiuve SE, et al. Prospective study of restless legs syndrome and coronary heart disease among women. Circulation. 2012; 126: 1689–1694.
67. Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology. 2004; 63: 1065–1069.
68. Littner MR, Kushida C, Anderson WM, et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004; 27: 557–559.
69. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep. 2005; 28: 891–898.